Takahashi, Manami
Takada, Ayaka
Suzuki, Chihiro
Kaminaga, Kiichi
Yoshioka, Masaki
Handa, Mariko
Kershaw, Jeff
Abe, Hiroshi
Ohshima, Takeshi
Igarashi, Ryuji
Takuwa, Hiroyuki
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP24K18089, JP23K2139)
Konica Minolta Imaging Science Foundation
Quantum Life Science Flagship Program (JPMXS0120330644, JPMXS0120330644)
Article History
Received: 31 March 2025
Accepted: 8 August 2025
First Online: 20 August 2025
Declarations
:
: Ethics and Consent to Participate declarations: All animal procedures were approved by the Institutional Animal Care and Use Committee of National Institutes for Quantum Science and Technology (Approval number: [23-1010-2]). All experiments were conducted in accordance with institutional guidelines and international standards, including the Basel Declaration.
: Not applicable.
: Kiichi Kaminaga is the CEO of Type-I Technologies Co., Ltd. Ryuji Igarashi and Kiichi Kaminaga have equity ownership in Type-I Technologies Co., Ltd. The other authors declare no competing interests.